Advances in molecular characterization of pediatric acute megakaryoblastic leukemia not associated with Down syndrome; impact on therapy development

Acute megakaryoblastic leukemia (AMKL) is a rare subtype of acute myeloid leukemia (AML) in which leukemic blasts have megakaryocytic features. AMKL makes up 4%–15% of newly diagnosed pediatric AML, typically affecting young children (less than 2 years old). AMKL associated with Down syndrome (DS) s...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jixia, Kalev‐Zylinska, Maggie L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267407/
https://www.ncbi.nlm.nih.gov/pubmed/37325571
http://dx.doi.org/10.3389/fcell.2023.1170622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267407/
https://www.ncbi.nlm.nih.gov/pubmed/37325571
http://dx.doi.org/10.3389/fcell.2023.1170622

Ejemplares similares